Natco Pharma Ltd. Conference Calls and Earnings Call Transcripts

29 May 2024

746.50

-3.07%

Earnings Call

NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Earnings call Audio Recording

28 May 2024

746.50

-3.07%

Natco Pharma Results Earnings Call for Q4FY24

Conference Call with Natco Pharma Management and Analysts on Q4FY24 Performance and Outlook. Listen to the full earnings transcript.

21 Feb 2024

746.50

-3.07%

Earnings Call

NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Concall Transcript for the quarter and nine months ended December 31, 2023

15 Feb 2024

746.50

-3.07%

Earnings Call

NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio recording of earnings conference call Q3 FY24

15 Feb 2024

746.50

-3.07%

Natco Pharma Results Earnings Call for Q3FY24

Conference Call with Natco Pharma Management and Analysts on Q3FY24 Performance and Outlook. Listen to the full earnings transcript.

21 Nov 2023

746.50

-3.07%

Earnings Call

NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Transcript for the Q2FY24 Concall

16 Nov 2023

746.50

-3.07%

Earnings Call

NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

BSE India

Audio recording of earnings conference call Q2 FY24

15 Nov 2023

746.50

-3.07%

Natco Pharma Results Earnings Call for Q2FY24

Conference Call with Natco Pharma Management and Analysts on Q2FY24 Performance and Outlook. Listen to the full earnings transcript.

14 Aug 2023

746.50

-3.07%

Earnings Call

NATCO PHARMA LTD. - 524816 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

BSE India

Earnings call transcript for the quarter ended June 30, 2023

10 Aug 2023

746.50

-3.07%

Natco Pharma Results Earnings Call for Q1FY24

Conference Call with Natco Pharma Management and Analysts on Q1FY24 Performance and Outlook. Listen to the full earnings transcript.